From the UCLA Integrated Substance Abuse Programs (L.J.M., S.G.-E., P.M.-C., M.H., J.H., W.L., R.R.), Los Angeles, CA; University of California School of Medicine (A.A.), Los Angeles, CA; and University of Hawaii School of Medicine (W.H., P.C.), Honolulu, HI.
J Addict Med. 2009 Sep;3(3):155-63. doi: 10.1097/ADM.0b013e3181a17c79.
: Medical conditions in methamphetamine (MA) users have not been well characterized. Using both self-report and physical examination data, the aims of this study were to (1) describe the frequency of medical conditions in a sample of MA users 3 years posttreatment; (2) evaluate the association between medical conditions and MA use frequency; and (3) examine the relationship of route of administration with medical outcomes.
: MA-dependent adults (N = 301) who participated in the Methamphetamine Treatment Project were interviewed and examined 3 years after treatment. Medical, demographic, and substance use characteristics were assessed using the Addiction Severity Index and Life Experiences Timeline. Current and lifetime medical conditions, electrocardiogram characteristics, and physical examination abnormalities were assessed.
: Among the most frequently reported lifetime conditions were wounds and burns (40.5%, N = 122) and severe dental problems (33%, N = 99), and a significant proportion of the sample evidenced prolonged corrected QT interval (19.6%, N = 43). Although health conditions were not associated with MA use frequency during follow-up, intravenous MA use was significantly associated with missing teeth (odds ratio = 2.4; 95% confidence interval, 1.2-4.7) and hepatitis C antibodies (odds ratio = 13.1; confidence interval, 5.6-30.1).
: In this sample of MA users, dental problems and corrected QT prolongation were observed at elevated rates. Although posttreatment MA use frequency was not associated with a majority of medical outcomes, intravenous MA use exacerbated risk for dental pathology and hepatitis C. Longer term follow-up research is needed to elucidate health trajectories of MA users.
美沙酮(MA)使用者的身体状况尚未得到充分描述。本研究旨在:(1)描述治疗后 3 年内 MA 使用者样本中的身体状况频率;(2)评估身体状况与 MA 使用频率之间的关联;(3)检查给药途径与医疗结果的关系。
参加美沙酮治疗项目的 MA 依赖成年人(N=301)在治疗后 3 年接受访谈和体检。使用成瘾严重程度指数和生活经历时间轴评估医学、人口统计学和物质使用特征。评估当前和终身的身体状况、心电图特征和体检异常。
在报告的最常见的终身疾病中,伤口和烧伤(40.5%,N=122)和严重的牙齿问题(33%,N=99)占比较大,样本中相当一部分存在 QT 间期延长(19.6%,N=43)。尽管身体状况与随访期间 MA 使用频率无关,但静脉 MA 使用与缺牙(比值比=2.4;95%置信区间,1.2-4.7)和丙型肝炎抗体(比值比=13.1;置信区间,5.6-30.1)显著相关。
在这个 MA 使用者样本中,观察到牙齿问题和 QT 间期延长的发生率较高。尽管治疗后 MA 使用频率与大多数身体状况结果无关,但静脉 MA 使用会加剧牙齿病理学和丙型肝炎的风险。需要进行更长期的随访研究,以阐明 MA 用户的健康轨迹。